Liothyronine Sodium Tablet
Product Images NDC 70771-1608

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Liothyronine Sodium (NDC 70771-1608). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (A3e28863 853a 49f5 9036 0b5b8367ca8d 01)

FDA Label Image

Label (A3e28863 853a 49f5 9036 0b5b8367ca8d 02)

FDA Label Image

Label (A3e28863 853a 49f5 9036 0b5b8367ca8d 03)

This is the description of a medication named Liothyronine which comes in tablet form. It consists of liothyronine sodium equivalent to 25 megs of liothyronine. The tablets should be stored in a tight container between 16 to 30°C. It is important to use safety measures when it is being dispensed. The package is child-resistant. The manufacturer of this medication is Zydus.*

FDA Label Image

Label (A3e28863 853a 49f5 9036 0b5b8367ca8d 04)

This is a drug package of Liothyronine Sodium Tablets. Each tablet contains fothyronine sodium, USP equivalent to 50 meg o ithyronine. The package has 100 tablets and is only for prescription use. The usual dosage information is mentioned. The product must be stored between 15° and 0°C. It is manufactured by Cata Healthcare Ltd., India.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.